Purchase Order 75N91023P00673
Award Date 9/1/23
Potential Completion Date 2/29/24
Potential Value $77K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02453, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Olink Proteomics AB was awarded a $31,130 firm fixed price delivery order against an unspecified contract vehicle to provide OLINK 1536 analysis services in support of the National Cancer Institute's Pediatric Oncology Branch programs. The services will be performed in Waltham, Massachusetts with work expected to be completed by December 16, 2022. The award was made by the Department of Health and Human Services' National Institutes of Health National Cancer Institute on December 15, 2021...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $50,688 firm fixed price delivery order to Olink Proteomics AB of Waltham, Massachusetts. The order is for Olink Target-96 Immuno-Oncology Analysis Service in support of the agency's Center for Immunology-Oncology programs. Performance will take place in Waltham from August 1, 2023 through January 31, 2024. No subcontractors or set aside designations were indicated. The delivery order...
- Olink Proteomics AB has been awarded a $10,078.96 purchase order by the National Institutes of Health's National Cancer Institute to provide biological and reagent materials for direct use. The firm fixed price contract runs from November 29, 2023 through December 31, 2023 and will be performed in Waltham, Massachusetts. No major subcontractors or set aside designations were indicated. The materials will support the National Cancer Institute's mission to lead the National Cancer Program and...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute to Olink Proteomics AB, a foreign-owned for-profit organization, to provide Olink Biomarker Analysis Services. The $249,250.00 contract has a performance period through May 16, 2024 and does not have a set-aside designation. Olink Proteomics specializes in multiplex protein biomarker analysis platforms and has previously supported NIH, Food and Drug...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $20,481 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts for biological products and services. The firm fixed price contract runs from November 13, 2023 through December 26, 2023 and will support the NIH NCI's research efforts. No subcontractors or set aside designations were identified. Olink Proteomics will provide biological materials to aid the NIH NCI in...
- This is a $30,625.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for Olink's EXPLORE HT proteomics analysis service, which provides high-multiplex protein biomarker discovery capabilities. Olink Proteomics has a history of providing proteomics instruments, reagents, and analysis services to...
- Olink Proteomics AB was awarded a firm fixed price, indefinite delivery contract valued at up to $1,214,788 by the National Institutes of Health National Institute on Drug Abuse to provide biological and reagent materials as well as proteomics analysis services. Specializing in proprietary multiplex protein biomarker analysis technologies, Olink will support biomedical research efforts through delivery of Olink Explore and Target multiplex protein analysis kits, reagents, array chips, and...
- This firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $13,184 contract is for a service agreement with a completion date of September 21, 2025. Olink Proteomics provides a range of proteomics instruments, reagent kits, integrated fluidic circuits, analysis services, and biological products to support biomedical...
- This is a firm fixed price purchase order for $34,902.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Olink Proteomics AB, a foreign-owned for-profit entity based in Sweden. The contract is for the delivery of Olink Proteomics' proprietary Inflammation reagent kits and Dynamic Array chips, which support multiplex protein biomarker analysis. This purchase order was awarded under simplified acquisition procedures...
- Olink Proteomics Inc. was awarded a firm fixed-price purchase order valued at ninety-nine thousand three dollars and fifty-five cents ($99,003.55) by the National Institutes of Health Clinical Center (NIH CC) to provide an Olink Signature Q100 instrument for research use by the Critical Care Medicine Department (CCMD). The contract has a period of performance from June 23, 2023 through July 22, 2023 and will be performed in Waltham, Massachusetts. No subcontractors or set-aside designations were...